Evidence map›Paper›PMID 40473463›Full record

Trial reportJournal of nuclear medicine : official publication, Society of Nuclear Medicine2025

Imaging Efficacy of [

Andrei Iagaru, Jose F Suarez, Spencer Behr, Rahul Aggarwal, Pilar Paredes, Nicolo Buffi, Thomas Penhoat, Francesco Ceci, Jochen Walz, Nicolas Doumerc and 8 more

Abstract readMulticenter StudyClinical Trial, Phase IIClinical Trial, Phase III
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Imaging Efficacy of [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Andrei IagaruStanford University, Stanford, California; aiagaru@stanford.edu.
Jose F SuarezDepartment of Urology, Bellvitge University Hospital, IDIBELL, Barcelona, Spain.
Spencer BehrUniversity of California San Francisco, San Francisco, California.
Rahul AggarwalUniversity of California San Francisco, San Francisco, California.
Pilar ParedesClinic Hospital Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain.
Nicolo BuffiDepartment of Biomedical Sciences, Humanitas University, Milan, Italy.
Thomas PenhoatLouis Pradel Hospital, Bron, France.
Francesco CeciIEO European Institute of Oncology IRCCS, University of Milan, Milan, Italy.
Jochen WalzInstitut Paoli-Calmettes Cancer Centre, Marseille, France.
Nicolas DoumercToulouse Hospitals, Toulouse, France.
Medge CoulangesAdvanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.
Zhongying XuNovartis Pharma AG, East Hanover, New Jersey.
Christelle SeigneNovartis Pharma AG, Basel, Switzerland.
Celine WilkeNovartis Pharma AG, Basel, Switzerland.
Ana M CatafauAdvanced Accelerator Applications, a Novartis Company, Geneva, Switzerland.
Stefano FantiNuclear Medicine, IRCCS AOU di Bologna, Bologna, Italy; and.
Tobias MaurerDepartment of Urology and Martini-Klinik Prostate Cancer Center, University of Hamburg-Eppendorf, Hamburg, Germany.
GuideView study investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[

Indexed as

Antigens, SurfaceFluorine RadioisotopesGlutamate Carboxypeptidase IIPositron Emission Tomography Computed TomographyProstatic NeoplasmsAgedHumansMaleMiddle AgedProspective StudiesAntigens, SurfaceFluorine RadioisotopesFOLH1 protein, humanGlutamate Carboxypeptidase II[18F]CTT1057high-risk prostate cancermolecular imagingPETprostate-specific membrane antigen

Identifiers

PMID40473463
PMCPMC12320564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.